Trypanosome trans-sialidase (TS) is a sialic acid-transferring enzyme that hydrolyzes a2,3-linked sialic acids and transfers them to acceptor molecules. Here we show that a highly purified recombinant TS derived from T. cruzi parasites targets TrkA receptors on TrkA-expressing PC12 cells and colocalizes with TrkA internalization and phosphorylation (pTrkA). Maackia amurensis lectin II (MAL-II) and Sambucus nigra lectin (SNA) block TS binding to TrkA-PC12 cells in a dosedependent manner with subsequent inhibition of TS colocalization with pTrkA. Cells treated with lectins alone do not express pTrkA. The catalytically inactive mutant TSDAsp98-Glu also binds to TrkA-expressing cells, but is unable to induce pTrkA. TrkA-PC12 cells treated with a purified recombinant a2,3-neuraminidase (Streptococcus pneumoniae) express pTrkA. Wild-type TS but not the mutant TSDAsp98-Glu promotes neurite outgrowth in TrkA-expressing PC12 cells. In contrast, these effects are not observed in TrkA deficient PC12 nnr5 cells but are reestablished in PC12 nnr5 cells stably transfected with TrkA and are significantly blocked by inhibitors of tyrosine kinase (K-252a) and MAP/MEK protein kinase (PD98059). Together these observations suggest for the first time that hydrolysis of sialyl a2,3-linked b-galactosyl residues of TrkA receptors plays an important role in TrkA receptor activation, sufficient to promote cell differentiation (neurite outgrowth) independent of nerve growth factor.
Introduction
The TrkA tyrosine kinase receptors are well known as signaling receptors for the neurotrophin nerve growth factors (NGFs) Miller, 1997, 2000) . Binding of NGF to the receptor induces Trk dimerization, activation, and internalization, which are the first essential steps leading to cell differentiation and survival responses in neurons (Kaplan and Miller, 2000; Meakin and Shooter, 1992) . The characteristic features of these TrkA receptors include a signal peptide, a single transmembrane domain, a catalytic region, a short C-terminal tail, and a ligandbinding domain rich in consensus N-glycosylation sites. The Trk glycosylation has been shown to be important for receptor maturation and localization to the cell membrane (Watson et al., 1999) . However, whether TrkA glycosylation plays a role in ligand binding, dimerization, kinase activation, and signal transduction is unknown.
Using the rat pheochromocytoma cell line PC12 and Schwann cells, Chuenkova et al. (2001; Chuenkova and Pereira, 2000) discovered that a highly purified transsialidase (TS) derived from T. cruzi parasites induced neurite outgrowth in these cells as well as mediated neuroprotection from apoptotic death caused by growth factor deprivation. These observations provided an important clue to a possible clinical significance of TS-mediated neuroprotection during the indeterminate phase in patients infected with T. cruz (Genovese et al., 1996; Koberle, 1968) . Indeed, most individuals infected with T. cruzi survive the acute infection to enter a subclinical, asymptomatic, indeterminate phase that lasts for decades. These patients showed no signs of peripheral neuropathy (Genovese et al., 1996) . Earlier studies of autopsied Chagas' disease cases revealed relatively few lesions in the autonomic nervous system of the heart and gastrointestinal tract (Koberle, 1968) . The average number of neurons actually increased with the age of the patient, in contrast to that found in the age-matched disease-free individuals (Koberle, 1968) . Furthermore, rodents infected with T. cruzi also showed signs of neurite development, axon regeneration, and sprouting in sympathetic nerve fibers of the heart and colon (Losavio et al., 1989; Machado et al., 1987) . Whether T. cruzi TS plays a neuroprotective role in these patients remains speculative. It is interesting to note here that T. cruzi TS has two unique catalytic properties (Colman and Smith, 2002; Lee and Kim, 2001) , one of which is the sialyltransferase activity that catalyzes the transfer of a2,3-linked sialic acids to terminal b-D-galactose acceptors, and the other is the sialidase activity that hydrolyzes these sialic acids from sialyloligosaccharides. It is intriguing to speculate that TS might target glycosylated Trk expressing neurons, hydrolyzing a2,3-linked sialic acids and inducing receptor internalization and activation.
In the present study, the rat pheochromocytoma cell line PC12 and its mutant Trk derivatives (MacDonald et al., 2000; Meakin et al., 1997 Meakin et al., , 1999a Meakin and MacDonald, 1998) were used as well-characterized models to further study the neuronal receptor involved in TS-mediated receptor activation and cell differentiation. We demonstrate that TS targets TrkA receptors and colocalizes with TrkA internalization and activation, which subsequently leads to neurite outgrowth in TrkA-expressing PC12 cells.
Results

T. cruzi TS activities
The recombinant TS and the mutant TSDAsp98-Glu used in these studies were isolated using the methylotrophic yeast Pichia pastoris system and further purified using an affinity anti-E-tag antibody column (Laroy and Contreras, 2000) . Both the wild-type TS and mutant TSDAsp98-Glu have the E-tag (pCAGGS-TSE) sequence linked to the C-terminus domain (Laroy and Contreras, 2000) . The mutant TSDAsp98-Glu has a point mutation in the catalytic domain of TS reducing the sialidase ( Figure 1A ) and sialyltransferase ( Figure 1B ) activities to~3.6% and 4.5%, respectively of the wild-type TS. In addition, the wild-type TS lacks the common glycosyltransferase structure and the C-terminal repeats and is glycosylated with terminal mannose branches (Laroy and Contreras, 2000) .
TS-induced neurite outgrowth in TrkA-expressing PC12 cells When naïve PC12 cells were treated with the wild-type TS for 3 days in culture, the cells extended neurites, but these were much shorter and fewer than those observed extending from NGF-treated cells (Figure 2 ). TS-treated TrkA-PC12 cells that overly express human TrkA by 100-fold compared to PC12 cells extended neurites similar to those observed for NGF-treated cells. In contrast, the mutant TSDAsp98-Glu was unable to induce neurite outgrowth in all cell types. The number of neurite-bearing PC12 cells following mutant TS treatment was markedly reduced compared to the NGF-or TS-treated group.
Furthermore, TS treatment of TrkA-deficient PC12 nnr5 cells did not induce neurite outgrowth after 3 days in culture ( Figure 2 ). Neurite outgrowth in PC12 nnr5 cells was not observed following treatment with NGF or with the mutant TSDAsp98-Glu for 3 days in culture.
To confirm that TrkA receptors may be involved in TS-induced neurite outgrowth, neurite extensions were TrkA-PC12, PC12, PC12 nnr5 , B2, or B5 cells were plated on poly-D-lysine-coated circular glass coverslides in 24-well tissue culture plates for 24 h. They were then treated for 3 days with wild-type TS (200 ng/ml), mutant TSDAsp98-Glu (200 ng/ml), or NGF (50 ng/ml) or were left untreated as controls. The cells were stained with phalloidin-rhodamine and revealed by fluorescence microscopy. Data represent the meansAESEM of independent experiments (n ¼ 4). Asterisk (Ã) represents significant differences at 95% confidence using Dunnett's multiple comparison test compared to control in each group. (mag 20-40Â, images enhanced by photo software).
TrkA receptor activation by trans-sialidase examined in TS-treated PC12 nnr5 cells stably transfected with rat TrkA receptors (B2 and B5 cells) (Meakin et al. 1997; Meakin and MacDonald, 1998) . TS-treated B5 cells that overly express TrkA receptors by 100-fold compared to PC12 cells extended neurites similar to those observed for NGF-treated cells (Figure 2 ). TS-treated B2 cells which overly express TrkA receptors by fourfold compared to PC12 cells extended neurites, but these were also much shorter and fewer than those observed extending from NGF-treated cells. These findings suggest that TS-induced neurite outgrowth in PC12 cells requires TrkA receptors.
When PC12 cells were pretreated with K252a, an inhibitor of Trk tyrosine kinase or PD98059, a MAP/MEK protein kinase inhibitor, the effects of NGF-and TS-induced neurite outgrowth in these inhibitor-treated cells were both blocked (Figure 3) . These results support the previous observations that TS-induced cell differentiation of naive PC12 cells involves TrkA tyrosine kinase as the signal generating receptor kinase and that the signal is transduced through the MAP/MEK protein kinase pathways for cell differentiation.
Localization of wild-type TS and mutant TSDAsp98-Glu binding to TrkA-PC12 cells To determine whether wild-type TS and mutant TSDAsp98-Glu bind to TrkA-expressing PC12 cells, TrkA-PC12 cells were treated with either TS or mutant TSDAsp98-Glu for 5, 15, 30, 60, and 120 min and then fixed, permeabilized, and immunostained with anti-E-tag antibodies. Immunofluorescence microscopy revealed that both wild-type TS and mutant TSDAsp98-Glu bound to TrkA-PC12 cells after 5 min treatment ( Figure 4A ). In contrast, there was no evidence of TS binding to TrkA deficient PC12 nnr5 cells ( Figure 4B ).
To establish the localization of TS binding to TrkA-PC12 cells, fluorescence confocal microscopy was used to analyze images captured using a z-stage of 8-10 images per cell at 0.5-mm steps. As shown in Figure 4C , TS treatment of TrkA-PC12 cells for 5 min showed TS localized to the membrane and the cytoplasm. After 30 and 60 min of treatment, the localization of both wild-type TS and mutant TSDAsp98-Glu binding was mainly confined to the cytoplasm.
TS induces phosphorylation (pTyr490) of TrkA receptors
If TS binds to TrkA receptors, we asked whether TS would induce phosphorylation of TrkA (pTrkA). We analyzed this question in fixed and permeabilized TrkA-PC12 cells using phospho-specific anti-pTyr490 Trk antibody and immunofluorescence microscopy. Following TS treatment of cells for 15, 30, 60, and 120 min, the immunostained cells revealed pTrkA after 15 min of treatment ( Figure 5A ). In contrast, these effects were not observed in TrkA-deficient PC12 nnr5 cells but were reestablished in PC12 nnr5 cells stably transfected with TrkA ( Figure 5A ).
To confirm TS-induced TrkA activation, NGF-and TStreated TrkA-PC12 cells were homogenized, and the lysates were further processed in a western blot with anti-pTyr490 antibody. The data in Figure 5B clearly show TS-induced pTrkA after 30 min treatment similar to that observed for a 15-min treatment with NGF. Blots of lysates from untreated control cells showed no pTrkA. If the hydrolysis of sialyl a-2,3-linked b-galactosyl residues by TS is involved in TrkA receptor activation, then treatment of TrkA-PC12 cells with a highly purified recombinant a2,3-neuraminidase (S. pneumoniae) that catalyzes the hydrolysis of nonreducing terminal a2,3 unbranched sialic acid residues should also induce pTrkA. The data in Figure 5B clearly show that a2,3-neuraminidase (S. pneumoniae) induced pTrkA in TrkA-PC12 cells 60 min after treatment similar to that observed for TS-treated cells. The data in Figure 5C show that the catalytically inactive mutant TSDAsp98-Glu did not induce pTrkA 60 min after treatment of TrkA-PC12 cells. This second blot was overdeveloped to show no signal following treatment with the mutant TS. Together these results suggest that the hydrolysis of sialyl a-2,3-linked bgalactosyl residues of TrkA receptors is involved in receptor activation.
TS colocalizes with pTrkA
If TS induces TrkA activation by binding to the receptor and catalyzing the hydrolysis of sialyl a-2,3-linked b-galactosyl residues, then TS should colocalize with phosphorylated TrkA (pTyr490). To test this, TrkA-PC12 cells were treated with TS for 5-, 15-, 30-, or 60-min intervals or were left untreated as controls. Cells were fixed, permeabilized, and immunostained simultaneously with monoclonal mouse anti-E tag antibody specific for TS and polyclonal rabbit anti-pTyr490 antibody specific for pTrkA followed by anti-mouse Alexa Fluor 488 (green) and anti-rabbit Alexa Fluor 568 (red). Cells were then visualized using a confocal inverted microscope (Leica TCS SP2 MP inverted Confocal Microscope) using a 100Â objective (oil). TS colocalized with pTrkA 15 min after treatment, and the amount of colocalization in the cell increased over a 60 min incubation with TS ( Figure 5D ). Considered together with the mutant TS data, these results show that TS targets TrkA receptors and colocalizes with receptor internalization and activation. During the 60-min period, the catalytic activity of TS hydrolyzes a2,3 linked sialic acids and this enzymatic reaction colocalizes with TrkA phosphorylation in the cytoplasm.
Lectin block of TS binding to TrkA-PC12 cells with subsequent inhibition of TS colocalization with TrkA activation
The specificity of TS binding to TrkA-PC12 cells was examined in a lectin inhibition of wild-type TS colocalization with phosphorylated TrkA receptors. TrkA-PC12 cells were first treated with MAL-II (Maackia amurensis lectin II, which binds preferentially to sialic acid in an a-2,3 linkage) or SNA (Sambucus nigra lectin, which binds to sialic acids attached to terminal galactose in an a-2,6 linkage and to a lesser degree a-2,3 linkage) for 30 min followed by TS for an additional 30 min. Cells were fixed, permeabilized, and immunostained simultaneously with monoclonal mouse anti-E tag antibody specific for TS and polyclonal rabbit anti-pTyr490 antibody specific for pTrkA followed by anti-mouse Alexa Fluor 488 (green) and anti-rabbit Alexa Fluor 568 (red). Cells were visualized using a confocal A. Woronowicz et al. inverted microscope (Leica TCS SP2 MP inverted confocal microscope) using a 100Â objective (oil). Both MAL-II and SNA blocked TS binding to TrkA-PC12 cells in a dosedependent manner with subsequent inhibition of TS colocalization with pTrkA ( Figure 6 ). Cells treated with lectins alone did not express pTrkA.
Discussion
The observations by Chuenkova and Pereira (2000) that T. cruzi TS was able to promote neurite outgrowth and neuronal survival responses suggested a novel mechanism of neuronal cell activation by TS. However, the neuronal receptor(s) targeted by TS had not been identified until Fig. 3 . K252a inhibitor of tyrosine kinase and PD98059 inhibitor of MAP/MEK protein kinase completely block NGF-and TS-induced neurite outgrowth in PC12 cells. Cells were plated on poly-D-lysine-coated circular glass coverslides in 24-well tissue culture plates for 24 h. They were pretreated with either 200 nM K252a or 20 mM PD98059 inhibitors for 20 min and then incubated for 5 days with 200 ng TS/ml or 50 ng NGF/ml. The cells were stained with phalloidin-rhodamine and revealed by fluorescence microscopy. Data represent the meanAESEM of independent experiments (n ¼ 4). Asterisks (Ã) represent significant differences at 95% confidence using Bonferroni's multiple comparison test. NGF versus control, p 5 0.001; TS versus control, p 5 0.001; inhibitors were not significant different from control in each group.
TrkA receptor activation by trans-sialidase now. In the present study, we demonstrate that TS binds to TrkA-expressing PC12 cells and colocalizes with TrkA internalization and activation. Similar treatment of TrkA-PC12 cells with a highly purified recombinant a2,3-neuraminidase (S. pneumoniae) was found to activate TrkA receptors. These findings suggest that the hydrolysis of sialyl a-2,3-linked b-galactosyl residues play an important role in TrkA receptor internalization and activation. (A) Wild-type TS and mutant TSDAsp98-Glu binding to TrkA-PC12 cells. Cells were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine for 24 h prior experimental treatment. Cells were treated with 200 ng/ml of either wild-type TS or mutant TSDAsp98-Glu for 5-, 15-, 30-, 60-, and 120-min intervals. They were then fixed, permeabilized, and immunostained with monoclonal anti-E tag antibody followed by anti-mouse Alexa Fluor 488 (green) and phalloidin-rhodamine (red: total cells). Cell staining was analyzed qualitatively using fluorescence microscopy (Aviovert 100A differential interference contrast imaging with a 40Â objective (bar ¼ 58.6 mm). The data are a representation of one out of two experiments showing similar results. (B) Lack of wild-type TS binding to TrkA-deficient PC12 nnr5 cells. Cells were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine for 24 h prior to experimental treatment. Cells were then treated with wild-ype TS for 5 and 15 min. They were then fixed, permeabilized, and immunostained with monoclonal anti-E tag antibody followed by anti-mouse Alexa Fluor 488 (green) and phalloidin-rhodamine (red: total cells). Cell staining was analyzed qualitatively using a fluorescence microscopy (Aviovert 100A differential interference contrast imaging with objective (mag 40Â or bar ¼ 58.6 mm). (C) Localization of wild-type TS binding to TrkA-PC12 and TrkA-deficient PC12 nnr5 cells. Cells were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine for 24 h prior to experimental treatment. Cells were treated with wild-type TS for 5, 30, and 60 min and mutant TSDAsp98-Glu for 60 min. Cells were then fixed, permeabilized, and immunostained with monoclonal anti-E tag antibody followed by anti-mouse Alexa Fluor 488 (green) and phalloidin-rhodamine (red). Cells were visualized using a confocal inverted microscope (Leica TCS SP2 MP inverted Confocal Microscope) with a 100Â objective (oil). Anti-mouse Alexa Fluor 488 was excited at 488 nm, and the emission was measured at 500-535 nm. Phalloidin-rhodamine was excited at 555 nm, and the emission was measured at 556-618 nm. Images were captured using a z-stage of 8-10 images per cell at 0.5-mm steps and were processed and merged using LCS Lite software. The data are a representation of one out of two experiments showing similar results.
A. Woronowicz et al.
A couple of models have been proposed to explain the enzymatic reactions of T. cruzi TS (Buschiazzo et al., 2000; Schenkman et al., 1994) . The substrate used by TS is the sialyl a-2,3-linked b-galactosyl residues that are common on glycoproteins, glycolipids, and oligosaccharides. TS does not transfer free sialic acid (Frasch, 2000; Schenkman et al., 1994) , and the sialyl a-2,6-, a-2,8-, and a-2,9-linked sialic acids are known to be poor donor substrates (Schenkman et al., 1994) . Structural analyses have shown that TS folds into two distinct domains: a catalytic b-propeller fold (~395 amino acids) tightly associated with a C-terminal (~247 amino acids) lectin-like domain with repeats of 12 amino TrkA-PC12 cells at 50% confluence were treated with either 200 ng/ml TS, 50 ng/ml NGF for 15 min, 50 or 100 mU/ml of a2,3-neuraminidase (S. pneumoniae) for 60 min, or left untreated as control. After lysis, cell lysates were resolved by 8% SDS-PAGE and the blots probed with polyclonal rabbit anti-phospho-Trk (pTrkA) antibody (anti-pY490) followed by Environ horseradish peroxidase-conjugated secondary anti-rabbit IgG antibody, and Western Lightning Chemiluminescence Reagent Plus. a2,3-Neuraminidase (S. pneumoniae) catalyzes the hydrolysis of nonreducing terminal a2,3 unbranched sialic acid residues from complex glycoproteins and carbohydrates. The enzyme exhibits no activity on a2,6-or a2,8-sialic acid linkages or on branched a2,3-sialic acid linkages. The blot is a representation of one out of two experiments showing similar results. (C) Mutant TSDAsp98-Glu does not induce TrkA phosphorylation (pTyr490). TrkA-PC12 cells were treated with either 200 ng/ml TS, 50 ng/ml NGF for 15 min, 200 ng/ml of mutant TSrAsp98-Glu, or were left untreated as control. After lysis, cell lysates were resolved by 8% SDS-PAGE and the blots probed with polyclonal rabbit anti-phospho-Trk (pTrkA) antibody (anti-pY490) followed by Environ horseradish peroxidase-conjugated secondary anti-rabbit IgG antibody and Western Lightning Chemiluminescence Reagent Plus. The blot is a representation of one out of two experiments showing similar results. (D) TS colocalizes with phosphorylated TrkA in TrkA-PC12 cells. Cells were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine for 24 h prior to experimental treatment. Cells were treated with 200 ng TS/ml for 5, 15, 30, and 60 min or left untreated as controls. Cells were then fixed, permeabilized, and immunostained with monoclonal anti-E tag antibody specific for E-tag sequence on TS followed by anti-mouse Alexa Fluor 488 (green) and polyclonal rabbit anti-phospho-Trk (anti-pY490) antibody followed by anti-rabbit Alexa Fluor 564. Cells were visualized using a confocal inverted microscope with a 100Â objective (oil). Images were captured using a z-stage of 8-10 images per cell at 0.5-mm steps and were processed and merged using LCS Lite software. To calculate the amount of colocalization in the selected image, the Pearson correlation coefficient was measured and expressed as a percentage using Image Pro Plus software. The data are a representation of one out of four experiments showing similar results.
TrkA receptor activation by trans-sialidase acids (SAPA repeats, 100-500 amino acids) in tandem (Buschiazzo et al., 2000 (Buschiazzo et al., , 2002 Frasch, 2000; Schenkman et al., 1994) . The lectin domain does not have any part in the catalytic activity of the enzyme, and there are no galactose binding sites present (Buschiazzo et al., 2002) . Using TS in combination with substrates and sialidase inhibitors, Buschiazzo et al. (2002) have found that a sialic acidinduced conformational switch activates the inactive free enzyme and concurrently modulates the binding affinity for the acceptor substrate. Both substrate binding sites are close to each other in the catalytic domain. According to this model of TS activity, the transfer reaction is preferred over the sialidase action because the sialic acid-induced conformational change makes the catalytic center more hydrophobic.
Site-directed mutagenesis experiments and the crystal structure of TS clearly demonstrated the crucial role of a few amino acid residues within the substrate-binding cleft in modulating the sialyltransferase activity (Buschiazzo et al., 2000 (Buschiazzo et al., , 2002 . The equivalent aspartic acid (Asp96) residue in bacterial and eukaryotic sialidases may indeed be important for sialic acid binding, but this interaction was found not to be the same in T. cruzi TS (Buschiazzo et al., 2002) . The Asp96 carboxylate in TS was shown to interact with the glycerol moiety of sialic acid substrate instead of the pyranose ring. Furthermore, Todeschini et al. (2004) have demonstrated that the inactive trans-sialidase has a b-galactoside recognition site formed following a conformational switch induced by sialoside binding, and this prior positioning of a sialyl residue is required for the b-galactoside interaction. The mutant TSDAsp98-Glu used in our studies has one additional amino acid (Ala24), and the start codon (Met) was included in our amino acid sequence, which may explain the difference in the amino acid number (Laroy and The test cells were then fixed, permeabilized, and immunostained simultaneously with monoclonal anti-E tag antibody specific for E-tag sequence on TS and polyclonal rabbit anti-phospho-Trk (anti-pY490) antibody followed by anti-mouse Alexa Fluor 488 (green) and anti-rabbit Alexa Fluor 568 (red). Cells were visualized using a confocal inverted microscope with a 100Â objective (oil). Images were captured using a z-stage of 8-10 images per cell at 0.5-mm steps and were processed and merged using LCS Lite software. Each bar in the figures represents the mean amplitudeAESEM of TS binding or pTrkA expression for all cells (n) within the respective images. Asterisk (Ã) represents significant differences at 95% confidence using Dunnett's multiple comparison test compared to control (Ctrl) in each group. The data are a representation of one out of three experiments showing similar results.
A. Woronowicz et al. Contreras, 2000) . Although Chuenkova and Pereira (2000) reported that TS-induced neurite outgrowth in PC12 cells was independent of the enzyme catalytic activity, the mutant TS that they used to demonstrate this had no transferase activity but still retained~68% of its sialidase activity (Chuenkova et al., 1999) . The mutant TSDAsp98-Glu used in our studies had a point mutation in the catalytic domain of TS reducing both the sialyltransferase and sialidase activities to~4.5% and 3.6%, respectively, of the wild-type TS. The mutant TSDAsp98-Glu bound to TrkA-expressing cells similarly like the wild-type TS and was subsequently internalized into the cytoplasm after 15 min. However, TSDAsp98-Glu did not induce TrkA Tyr490 phosphorylation 60 min after treatment. It was also unable to mediate neurite outgrowth in TrkA-PC12 cells.
Considered together, the results indicate that the sialidase and not the sialyltransferase activity of wild-type TS was involved in activating TrkA receptors. Similar findings were observed using a highly purified recombinant a2,3-neuraminidase (S. pneumoniae). It is important to note that the actual physical binding of wild-type TS, mutant TSDAsp98-Glu, or sialic acid-specific lectins to TrkA-expressing cells is not sufficient to induce TrkA receptor activation. In support of this, Todeschini et al. (2002a) have shown that their inactive mutant of trans-sialidase (irTS) can physically interact with CD4þ T cells and that this binding of irTS to T cells was abrogated by the prior incubation of irTS with a2-3-sialyllactose but not with a2-6-sialyllactose, demonstrating the specificity of the interaction of irTS with a2-3-linked sialic acids. In addition, Todeschini et al. (2002b) demonstrated that their native and recombinant TSs alone failed to induce T cell mitogenesis but were able to costimulate CD4þ T cell activation in vitro only in the presence of phorbol 12-myristate 13-acetate as the costimulus.
Here we propose a model of TrkA activation based on the glycosylation state of the receptors. TS binding to TrkAexpressing cells colocalizes with TrkA phosphorylation in cytoplasmic vesicles after 15 min. This interaction is specifically abrogated in a dose-dependent manner with MAL-II and SNA lectins, which bind preferentially to sialic acids attached to terminal galactose in a-2,3 and a-2,6 linkages, respectively. It is interesting to note that although TS interacts with the glycerol moiety of sialic acid substrate instead of the pyranose ring, both lectins were still able to block TS binding to TrkA-PC12 cells with subsequent inhibition of TrkA activation. A possible explanation for this may be due to the large size of the lectins (MAL-II, a molecular weight of 140,000 Da and SNA 150,000 Da). Following TS binding to TrkA receptors, it is the hydrolysis of sialyl a-2,3-linked b-galactosyl residues of TrkA receptors by TS that may be important in facilitating the dimerization of Trks and subsequent phosphorylation of Tyr490 residues. For Trk receptors, glycosylation is required to localize the receptors to the cell surface where it prevents ligand-independent activation of receptors (Watson et al., 1999) . Our results suggest that sialyl a-2,3-linked b-galactosyl residues of TrkA receptors may be the important sugar property required for cell surface Trk expression, and the hydrolysis of these residues would subsequently facilitate Trk receptor internalization, dimerization, and phosphorylation. Phosphorylated TrkA receptors would then lead to the activation of downstream signaling molecules, such as MAP/MEK protein kinases. Indeed, phosphorylation of Trk Tyr490 has been shown to be a requirement for Shc association and recruitment of FRS2/Crk (Meakin et al., 1999b) , both of which might be the likely source for long-term mitogen-activated protein kinase (MAPK) activation (phospho-MAPK) (Encinas et al., 1999; Yoon et al., 1997) . Phosphorylation of MAPK would suggest internalization of phosphorylated Trk receptors (Watson et al., 2001) . In support of this concept we have shown, using inhibitors of tyrosine kinase and MAP/MEK protein kinase, that both NGF-and TSinduced neurite outgrowth in PC12 cells were completely blocked.
There is an extensive body of literature on the cellular role of sialic acids (Brockhausen and Kuhns, 1997; Schauer et al., 1997; Schauer, 1982 Schauer, , 2000 Varki, 1993) , but there are only few examples of a role of sugars in signal transduction. One is the addition of a single O-linked carbohydrate modification, which is essential for Notch signaling (Moloney et al., 2000) . Furthermore, transfection of PC12 cells with core 2 GlcNAc transferase resulted in increased Trk receptor levels and phosphorylation as well as increased PC12 differentiation in the absence of NGF (Koya et al., 1999) . Trk activity was also modified when PC12 cells were transfected with GlcNAc-transferase III (Ihara et al., 1997) , an enzyme in the N-glycan pathway, or with ganglioside GD3 synthase gene (GD3 synthase is a ganglioside-specific sialyltransferase) (Fukumoto et al., 2000) .
TrkA receptors are distributed at the plasma membrane as a type I membrane protein with the N-terminus located extracellularly. The total number of potential N-glycosylation sites ranges from 11 to 15 in the various TrkA, TrkB, and TrkC sequences (Watson et al., 1999) . The structures of N-glycans on Trk receptors are unknown. It has been suggested that TrkA might be O-glycosylated (Koya et al., 1999) . Watson et al. (1999) have shown that unglycosylated TrkA core protein is fully activated as a signal-generating receptor tyrosine kinase, but it is mislocalized or trapped intracellularly and is not transduced through the Ras/MAP/ MEK and Erk kinase pathways, and the cells do not display features of cellular differentiation. This property of glycosylation has been shown for a number of other cell surface receptors (Brockhausen and Kuhns, 1997) . However, the exact role of Trk receptor glycosylation for the neurotrophin NGF binding, receptor dimerization, kinase activation, and signal transduction has not been defined yet.
The findings in these studies suggest for the first time an important sugar property of TrkA tyrosine kinase receptors playing a role in their activation. They suggest that the hydrolysis of sialyl a-2,3-linked b-galactosyl residues on Trk receptors by TS is sufficient to trigger receptor internalization and activation, signal transduction, and cell differentiation.
Material and methods
Recombinant TS
The recombinant TS and the mutant TSDAsp98-Glu used in these experiments were isolated using the methylotrophic TrkA receptor activation by trans-sialidase yeast P. pastoris system and further purified using an affinity anti-E-tag antibody column (Laroy and Contreras, 2000) . Both the wild-type TS and mutant TSDAsp98-Glu had the E-tag (pCAGGS-TSE) sequence linked to the Cterminus domain (Laroy and Contreras, 2000) . The mutant TSDAsp98-Glu had a point mutation in the catalytic domain of TS reducing the enzymatic activity to~3.6% of the wild-type activity. The sialidase activity of the enzymes was measured in Tris-buffered saline, pH 7.6, containing 0.2 mM 4-methylumbelliferyl-N-acetylneuraminic acid at a temperature of 25 C. After 15 min incubation, the reaction was stopped and the fluorescence of free 4-methylumbelliferone was measured with a CYTOFLUOR, Multi-Well Plate Reader Series 4000 (PerSeptive Biosystems, Brussels, Belgium). Data represent the means AE SD of two independent measurements. The sialyltransferase activity of the wild-type TS and the mutant TSDAsp98-Glu was measured in HEPES buffer, pH 7.2, containing 20 mM N-acetylneuraminyl lactose and 220 nM 8-aminopyrene-1,3,6-trisulfonic acid-labeled NA2FB sugar structures (asialo-, galactosylated biantennary, core-substituted with fucose and with bisecting GlcNAc). The NA2FB sugar structures were labeled and purified according to Callewaert et al. (2001) . Fifty nanograms of enzyme was added and the reaction was incubated at 25 C for 30 min. For the analysis of the glycan structures, DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) was used as previously described (Callewaert et al., 2001) .
The optimal dose of 200 ng TS/ml was determined for neurite outgrowth in PC12 cells in a 3 day culture.
NGF and inhibitors NGF (Sigma, St. Louis, MO) was used at a predetermined optimal dosage of 50 ng/ml. K-252a (Calbiochem, San Diego, CA), an inhibitor of Trk tyrosine kinase, and PD98059 (Calbiochem), an inhibitor of MAP/MEK protein kinase, were used at predetermined optimal dosages of 200 nM for K-252a and 20 mM for PD98059.
Cell lines
The NGF-responsive PC12 rat pheochromocytoma cell line, PC12 nnr5 (tyrosine kinase-deficient mutant, NGF nonresponsive) Miller, 1997, 2000) , TrkA-PC12 cell line (overly expressing human TrkA receptors) (Hempstead et al., 1992) , and the PC12 nnr5 cell lines stably transfected with rat TrkA receptors (B5 and B2) (Meakin and MacDonald, 1998) were used in these studies. All cell lines were grown at 37 C in 5% CO 2 in culture media containing RPMI 1640 (Gibco, Rockville, MD) supplemented with 5% horse serum and 5% fetal calf serum (Gibco).
Scoring of neurite outgrowth
Cells (~5Â 10 6 /glass slide) were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine (Sigma) for 24 h prior to experimental treatment. After 2-3 days of treatment, the cells were fixed in 3.7% paraformaldehyde for 30 min, permeabilized with 0.2% Triton X-100 in phosphate buffered saline on ice for 5 min, followed with a blocking solution of 3% bovine serum albumin on ice for 20 min. The cells were then stained with phalloidin-rhodamine (Sigma) for 1 h at 37 C. The stained cells were air-dried and mounted on microscope slides. Cell staining was analyzed qualitatively using fluorescence microscopy (Aviovert 100A DIC imaging) and quantitatively by counting the number of cells with multiple neurite extensions (!200 of the total cells; one or more extensions greater than 2 cell bodies in length).
pTyr490 and internalization in TrkA-PC12 cells Cells were grown in 24-well tissue culture plates on 12-mm circular glass slides coated with poly-D-lysine for 24 h prior to experimental treatment. Cells were treated with 200 ng/ml TS for 15-, 30-, or 60-min intervals or with 50 ng/ml NGF for 15 min. They were then fixed in 3.7% paraformaldehyde, permeabilized with 0.2% Triton X-100 in phosphate buffered saline on ice for 5 min, and immunostained with the polyclonal rabbit anti-phospho-Trk (anti-pY490) antibody (anti-pY490; kind gift from Dr. Rosalind Segal, Dana Farber) followed by anti-rabbit Alexa Fluor 488 (green) and phalloidin-rhodamine (red) for 1 h at 37 C. Cell staining was analyzed qualitatively using either fluorescence microscopy (Aviovert 100A DIC imaging) or a confocal inverted microscope (Leica TCS SP2 MP inverted Confocal Microscope) using a 100Â objective (oil). Anti-rabbit Alexa Fluor 488 was excited at 488 nm, and the emission was measured at 500-535 nm. Phalloidinrhodamine was excited at 555 nm, and the emission was measured at 556-618 nm. In the colocalization experiments, cells were fixed, permeabilized, and immunostained simultaneously with monoclonal mouse anti-E tag antibody specific for TS and polyclonal rabbit anti-pTyr490 antibody specific for pTrkA followed by anti-mouse Alexa Fluor 488 (green) and anti-rabbit Alexa Fluor 568 (red). Images were captured using a z-stage of 8-10 images per cell at 0.5 mm steps and were processed and merged using LCS Lite software.
Lectin inhibition of TS colocalization with pTrkA
TrkA-PC12 cells were first treated with 10, 1, or 0.1 mg/ml MAL-II or with 10, 1, or 0.1 mg/ml SNA for 30 min followed by 200 ng/ml of wild-type TS for an additional 30 min. Control cells were either untreated, TS-treated alone, or lectin-treated alone at a dose of 10 mg/ml. As previously described, cells were then fixed, permeabilized, and immunostained simultaneously with monoclonal mouse anti-E tag antibody specific for TS and polyclonal rabbit anti-pTyr490 antibody specific for pTrkA followed by anti-mouse Alexa Fluor 488 (green) and anti-rabbit Alexa Fluor 568 (red). Cells were visualized using a confocal inverted microscope (Leica TCS SP2 MP inverted) using a 100Â objective (oil).
pTyr490 TrkA immunoblot analysis TrkA-PC12 cells were treated with 200 ng/ml TS for 60 min, 50 ng/ml NGF for 15 min, or were left untreated as controls (Ctrl). Cell preparations were homogenized in lysis buffer containing Tris-buffered saline, 1% v/v NP40, 10% v/v glycerol, 2 ml/ml aprotinin, 2 ml/ml leupeptin, and 5 ml/ml A. Woronowicz et al. phenylmethanesulfonyl fluoride, and further microcentrifuged to remove nuclei. The lysates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 8% gels, transferred to polyvinylidene difluoride Immobilon membranes, and processed for blotting against anti-phospho-Tyr490 antibodies (anti-pY490), horseradish peroxidase-conjugated secondary antibody and Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer, Boston, MA).
Statistics
Comparisons between two groups were made by one-way analysis of variance at 95% confidence using Bonferroni's multiple comparison test, or Dunnett's multiple comparison test for comparisons among more than two groups.
